C4 Therapeutics, Inc. (CCCC) NASDAQ
4.50
+0.125(+2.86%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.50
+0.125(+2.86%)
Currency In USD
| Market Cap | 158.33M |
| Enterprise Value | 143.71M |
| P/E Ratio | -5.46 |
| PEG Ratio | -0.33 |
| Price/Sales Ratio | 10.68 |
| Price/Book Ratio | 2.42 |
| Enterprise/Revenue | 10.6 |
| Enterprise/EBITDA | -3.41 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -2.98 |
| Operating Margin | -3.27 |
| Return On Assets | -0.32 |
| Return On Equity | -0.51 |
| Revenue | 35.95M |
| Revenue/Share | 0.28 |
| Gross Profit | 27.97M |
| EBITDA | -102.91M |
| Net Income | -104.99M |
| Diluted EPS | -1.27 |
| Total Cash | 235.67M |
| Total Cash/Share | 1.87 |
| Total Debt | 58.45M |
| Total Debt/Equity | 0.25 |
| Current Ratio | 9 |
| Book Value Per Share | 1.86 |
| 52-Week Change | 237.97 |
| 52-Week High | 4.6 |
| 52-Week Low | 1.27 |
| Moving Average 50 Days | 2.99 |
| Moving Average 200 Days | 2.56 |
| Average Volume | 2.96M |
| Shares Outstanding | 82.83M |
| % Held by Institutions | 101.93 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |